Latest Articles
P. D. Hinduja Hospital & MRC launched Multidisciplinary Endometriosis Clinic - IndiaMedToday
P. D. Hinduja Hospital & MRC launched Multidisciplinary Endometriosis Clinic IndiaMedToday
Published: May 24, 2026, 9:12 a.m.
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints Yahoo Finance
Published: May 23, 2026, 12:01 p.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results - Yahoo Finance
How Investors Are Reacting To Merck (MRK) TroFuse ADC’s Breakthrough Endometrial Cancer Phase 3 Trial Results Yahoo Finance
Published: May 20, 2026, 6:22 p.m.
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story - simplywall.st
How Sacituzumab Trial Success In Endometrial Cancer At Merck (MRK) Has Changed Its Investment Story simplywall.st
Published: May 20, 2026, 5:46 a.m.
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T - GuruFocus
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T GuruFocus
Published: May 18, 2026, 10:39 p.m.
Mini PC deal: Get 47% off the KAMRUI Pinova P2 at Amazon - Mashable
Mini PC deal: Get 47% off the KAMRUI Pinova P2 at Amazon Mashable
Published: May 17, 2026, 6:36 p.m.
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 - OncLive
Four-Year Follow-Up Outcomes in dMMR Endometrial Cancer Presented at SGO 2026 OncLive
Published: May 6, 2026, 12:02 p.m.
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus - The ASCO Post
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus The ASCO Post
Published: April 26, 2026, 9 p.m.
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma - The ASCO Post
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma The ASCO Post
Published: April 26, 2026, 9 p.m.
Link copied to clipboard!